Quantcast
Last updated on April 24, 2014 at 5:22 EDT

Latest Crystal Research Associates LLC Stories

2009-02-13 15:00:00

NEW YORK, Feb. 13 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an updated Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. (BNC: TSX). The full 68-page report can be found at www.crystalra.com. Bioniche Life Sciences Inc. ("Bioniche" or "the Company") is a Canadian biopharmaceutical company that aims to improve the quality of life in both humans and animals through innovative research, technologies, and therapeutics....

2009-01-13 07:30:00

NEW YORK, Jan. 13 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. (BLU: TSX). The full 52-page report can be found at www.crystalra.com. BELLUS Health Inc. ("BELLUS Health" or "the Company") is a global health company focused on providing innovative pharmaceutical and nutraceutical solutions for critical unmet needs. BELLUS Health aims to generate revenue in the short to medium...

2009-01-07 07:30:00

NEW YORK, Jan. 7 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Unilife Medical Solutions Limited (UNI-ASX). The full 72-page report can be found at www.crystalra.com and www.unilife.com. Unilife Medical Solutions Limited ("Unilife" or "the Company") develops and supplies innovative safety medical devices to healthcare and pharmaceutical markets. Specifically, the Company is focused on targeting...

2008-08-20 15:01:11

NEW YORK, Aug. 20 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation . The full 64-page report can be found at http://www.crystalra.com/. Generex Biotechnology Corporation ("Generex" or "the Company") is a specialty pharmaceutical company that aims to research, develop, and commercialize drug delivery systems and technologies to treat autoimmune disorders, cancers, and...